JD Health International Inc. (JDHIF)
OTCMKTS · Delayed Price · Currency is USD
6.27
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
JD Health International Revenue
In the year 2024, JD Health International had annual revenue of 58.16B CNY with 8.65% growth. JD Health International had revenue of 29.82B in the half year ending December 31, 2024, with 12.47% growth.
Revenue
58.16B CNY
Revenue Growth
+8.65%
P/S Ratio
2.49
Revenue / Employee
16.32M CNY
Employees
3,564
Market Cap
19.87B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.16B | 4.63B | 8.65% |
| Dec 31, 2023 | 53.53B | 6.79B | 14.54% |
| Dec 31, 2022 | 46.74B | 16.05B | 52.32% |
| Dec 31, 2021 | 30.68B | 11.30B | 58.30% |
| Dec 31, 2020 | 19.38B | 8.54B | 78.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |